SEC Form 4 · accession 0001209191-18-014690
PURE BIOSCIENCE, INC. · PURE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Stuart Elliott
Officer — Vice President, Finance
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 7:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001006028
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $0.78 | Feb 26, 2018 | A | 150,000 | A | — | Feb 26, 2023 | Common Stock | 150,000 | 150,000 | D |
| Stock Options (Right to Buy)F3 | $1.15 | Feb 26, 2018 | D | 150,000 | D | — | May 11, 2018 | Common Stock | 150,000 | 0 | D |
| Stock Options (Right to Buy)F3 | $1.15 | Feb 26, 2018 | A | 150,000 | D | — | May 11, 2021 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F125% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018.
- F2The two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 11, 2016 with an exercise period of 2 years. The term of the option has been amended to extend the exercise period to five years from the date of grant.
- F325% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on August 11, 2016.